Article | October 12, 2022

Key Considerations When Transferring Drug Products Into Barrier Systems

Source: Syntegon Pharma Technology Inc.

By Matthias Angelmaier

GettyImages-503624976-lab-cleanroom-research-computer

When transferring products and materials into barrier systems, there are many things to consider. It begins with categorizing the pharmaceutical product and defining the aseptic environment along with asking a baseline of initial questions including how a product is categorized, what processes and procedures are commonly used, and what the major challenges in product and component supply are.

There are numerous considerations to be taken into account when planning aseptic production. Often, shortcomings are only revealed at a very late planning stage or – in the worst case – during production. Older installations without sufficient barrier or lower categorization are increasingly being upgraded in the direction of at least RABS, as worldwide authorities regulations increasingly demand this. Therefore, it is highly recommended that strong and experienced partners who can provide comprehensive advice based on decades of experience be relied upon during facility and transfer systems design.

Read to learn about maintaining aseptic barriers, the different needs for different packaging types, and more.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online

Syntegon Pharma Technology Inc.